PhD/MD degree at the same University in 1985. He also holds a PhD degree in Biology (Autonomous University of Madrid, 1992) . Dr Kroemer's team discovered in 1994 that mitochondrial membrane permeabilization is a critical step in programmed cell death, thus allowing for a biochemical redifinition of apoptosis. The group is actually working on the molecular mechanisms of this permeabilization step and its control by oncoproteins from the Bcl-2 family. Furthermore, Dr Kroemer is establishing the mechanistic links between mitochondria and the activation of catabolic enzymes involved in the death process. He is also characterizing the biochemical mechanisms that define nonapoptotic death modalities. His group undertakes particular efforts to apply this fundamental knowledge to two pathologies linked to a dysregulation of apoptosis, namely the mechanisms of chemotherapy resistance of cancer cells and the induction of cell death by human immunodeficiency virus-1. 
